XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Issue Of Common Stock Prefunded Warrants And Common Stock Warrants Sold For Cash [Member]
Issue Of Common Stock Prefunded Warrants And Common Stock Warrants Sold For Cash [Member]
Common stock [Member]
Issue Of Common Stock Prefunded Warrants And Common Stock Warrants Sold For Cash [Member]
Additional Paid-in Capital [Member]
Balance at the beginning at Jun. 30, 2023 $ 202 $ 0 $ 168,921 $ (167,889) $ (830)      
Balance at the beginning (In shares) at Jun. 30, 2023   1,671,485            
Issuance of common stock, pre-funded warrants, and common warrants sold for cash, net of offering costs of $2,964 27,919 $ 0 27,919          
Issuance of common stock, pre-funded warrants, and common warrants sold for cash, net of offering costs of $2,964 (In Shares)   875,949            
Issuance of common stock and pre-funded warrants sold for cash, net of offering costs   $ 1       $ 37,072   $ 37,071
Issuance of common stock and pre-funded warrants sold for cash, net of offering costs (In Shares)             5,749,152  
Exercise of pre-funded warrants, Shares   953,307            
Exercise of Series 2 warrants 190   190          
Exercise of Series 2 warrants (In shares)   98,039            
Exercise of common warrants 2,848   2,848          
Exercise of common warrants (Shares)   738,187            
Anti-dilution adjustment to warrants     619 (619)        
Share-based compensation 830   830          
Foreign currency translation gain (loss) (62)       (62)      
Net Income (Loss) (21,751)     (21,751)        
Balance at end at Jun. 30, 2024 47,248 $ 1 238,398 (190,259) (892)      
Balance at end (In shares) at Jun. 30, 2024   10,086,119            
Foreign currency translation gain (loss) (101)              
Net Income (Loss) (5,059)              
Balance at the beginning at Jun. 30, 2024 47,248 $ 1 238,398 (190,259) (892)      
Balance at the beginning (In shares) at Jun. 30, 2024   10,086,119            
Balance at the beginning at Jun. 30, 2024 47,248 $ 1 238,398 (190,259) (892)      
Balance at the beginning (In shares) at Jun. 30, 2024   10,086,119            
Balance at the beginning at Jun. 30, 2024 47,248 $ 1 238,398 (190,259) (892)      
Balance at the beginning (In shares) at Jun. 30, 2024   10,086,119            
Issuance of common stock and pre-funded warrants sold for cash, net of offering costs   $ 1       $ 28,208   $ 28,207
Issuance of common stock and pre-funded warrants sold for cash, net of offering costs (In Shares)             2,043,000  
Exercise of pre-funded warrants, Shares   2,374,583            
Exercise of Series 2 warrants 2,999   2,999          
Exercise of Series 2 warrants (In shares)   1,553,927            
Exercise of common warrants 39,278   39,278          
Exercise of common warrants (Shares)   10,192,840            
Share-based compensation 17,426   17,426          
Foreign currency translation gain (loss) 53       53      
Net Income (Loss) (37,917)     (37,917)        
Balance at end at Jun. 30, 2025 97,295 $ 2 326,308 (228,176) (839)      
Balance at end (In shares) at Jun. 30, 2025   26,250,469            
Foreign currency translation gain (loss) (123)              
Net Income (Loss) (8,805)              
Balance at end at Jun. 30, 2025 $ 97,295 $ 2 $ 326,308 $ (228,176) $ (839)      
Balance at end (In shares) at Jun. 30, 2025   26,250,469